Works matching IS 17562856 AND DT 2015 AND VI 8 AND IP 2

Results: 4
    1
    2

    A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing–remitting multiple ...

    Published in:
    Therapeutic Advances in Neurological Disorders, 2015, v. 8, n. 2, p. 59, doi. 10.1177/1756285615572953
    By:
    • Zivadinov, Robert;
    • Dwyer, Michael;
    • Markovic-Plese, Silva;
    • Hayward, Brooke;
    • Bergsland, Niels;
    • Heininen-Brown, Mari;
    • Carl, Ellen;
    • Kennedy, Cheryl;
    • Dangond, Fernando;
    • Weinstock-Guttman, Bianca
    Publication type:
    Article
    3

    The emerging role of tacrolimus in myasthenia gravis.

    Published in:
    Therapeutic Advances in Neurological Disorders, 2015, v. 8, n. 2, p. 92, doi. 10.1177/1756285615571873
    By:
    • Cruz, Jennifer L.;
    • Wolff, Marissa L.;
    • Vanderman, Adam J.;
    • Brown, Jamie N.
    Publication type:
    Article
    4